Innovation fatigue can be defined broadly as a negative impression of what is characterized as innovation caused by the overuse of the term, poorly-executed initiatives, internal misalignment and innovation for the sake of innovation.
The etiologies of innovation fatigue are:
Signs and symptoms of innovation fatigue are:
Recent advances in treatment include:
Chronic innovation fatigue syndrome is endemic to geographic areas but is spreading rapidly. It is one of the many reasons why your innovation initiative will fail.
For of most corporations and businesses, this organizational immune system is the primary force responsible for resisting disruptive innovation and hindering the implementation of the key attributes needed for exponential growth and long-term success. It’s what stops most companies from creating something as big as AWS.
As yet, there is no vaccine to prevent activation of the corporate immune system, but here are some ways to overcome it.
Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs on Twitter@ArlenMD.
Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at www.bridgehealth.com and www.cliexa.com and Chairman of the Board at GlobalMindED at www.globalminded.org, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.